SOCAR was founded in 1986, and has more than 25 years of experience in the design, conduct, analysis and reporting of phase I to IV clinical studies. Since our founding, SOCAR has become a leading independent clinical research organisation by delivering unparalleled expertise and service to our customers. Today, our clinical expertise, academic and opinion leader network and operational capabilities enable us to serve our clients worldwide and empower them to safely, efficiently and more quickly commercialise drugs and devices.
Offices in :
Dr. Bridget-Anne Kirwan, FESC CEO & CSO 18, chemin de Chantemerle CH-1260 NYON Switzerland